Who Gets Canker Sores? The Epidemiology of RAS

TL;DR

Canker sores (recurrent aphthous stomatitis, or RAS) affect roughly 20% of the general population, but that average obscures large variation. The groups most reliably affected: women (at about 1.5–2× the rate of men, driven by hormonal cycles), adolescents and young adults (peak onset between ages 10–19, declining steadily after 30), and anyone with a first-degree relative who has RAS (family history is the single strongest predictor). Higher socioeconomic status and education correlate with more canker sores, not fewer — counterintuitive and probably related to the hygiene hypothesis. People with certain autoimmune and gastrointestinal conditions (celiac disease, Crohn's, IBD) have significantly elevated rates, usually because the underlying condition drives the nutritional deficiencies that lower mucosal threshold. Race, as an isolated variable, does not appear to be a meaningful driver — the genetic factors that matter are immune system and HLA type, not ancestry broadly.

Overall Prevalence: More Common Than You Think

RAS is one of the most common oral mucosal conditions in the world. Prevalence estimates across large population studies range from 5% to 25%, with most landing around 15–20% when recurrent episodes are the criterion (Porter et al., 1998 — PMID: 9827252; Axéll & Henricsson, 1985 — PMID: 3860042).

That means roughly 1 in 5 people experiences RAS at some point — but the frequency of outbreaks varies enormously. Some people have one or two episodes per year; others (the population most likely to be reading this) cycle almost continuously.

The more useful question than "do you get canker sores?" is "how often?" — and the frequency distribution is heavily skewed. A minority of sufferers account for the majority of episodes.

Sex: Women Are More Affected Than Men

Women develop RAS at roughly 1.5 to 2 times the rate of men across most studies (Shulman, 2004 — PMID: 15060395; Rogers, 1997 — PMID: 9290927). The disparity is consistent across different countries and study methodologies, which makes it one of the most reliable epidemiological findings in RAS research.

The Hormonal Mechanism

The sex difference isn't arbitrary — it maps onto hormonal fluctuation. Multiple lines of evidence point to estrogen and progesterone as modulators of mucosal immunity:

Luteal phase timing: A significant subset of women with RAS report outbreaks clustered in the premenstrual phase — when progesterone drops sharply and estrogen falls from its mid-cycle peak. Studies tracking canker sore occurrence against menstrual cycle phase show this clustering is real, not just perception (Ferguson et al., 1984 — PMID: 6590802).

Oral contraceptive effect: Some women report that starting combined oral contraceptives suppresses canker sore frequency, while others report increased frequency — a result consistent with the fact that different OCP formulations produce different hormonal environments and different women have different baseline sensitivity. The relationship is real but not uniform.

Pregnancy remission: Many women with RAS report near-complete remission during pregnancy, when progesterone and estrogen are sustained at high levels rather than cycling. This is strong circumstantial evidence that hormonal stability, rather than any specific hormone level, reduces susceptibility (Ship et al., 1961 — PMID: 13774544).

Proposed mechanism: Estrogen receptors are present on oral mucosal cells. Estrogen appears to support mucosal epithelial integrity and modulate the local T-cell response. The rapid withdrawal of estrogen in the late luteal phase may lower the threshold for the CD8+ T-cell attack that produces aphthous ulcers in genetically susceptible individuals.

Herpetiform Subtype

The sex disparity is even more pronounced for herpetiform canker sores — the rare subtype characterized by clusters of 10–100 tiny ulcers. Herpetiform RAS shows a strong female predominance and tends to present in older adults rather than adolescents, distinguishing it epidemiologically from the more common minor aphthous type.

Age: Highest in Adolescence, Declining After 30

The onset of RAS is strongly age-patterned. First episode most commonly occurs between ages 10 and 19, with prevalence peaking in the teenage and young adult years (Shulman, 2004 — PMID: 15060395). After age 30, prevalence and frequency both decline, and after age 60, RAS is considerably less common.

Why the Teen Peak?

Several converging factors explain the adolescent concentration:

Immune system maturation: The adaptive immune system is still calibrating during adolescence. The specific immune dysregulation underlying RAS — a cell-mediated response in which CD8+ cytotoxic T-cells attack oral epithelium — may be more likely to arise and recur during a period of active immune system development.

Hormonal onset: Puberty introduces the hormonal cycling that, as discussed above, appears to lower mucosal threshold in susceptible individuals. For girls especially, the onset of RAS often tracks the onset of menstruation.

Nutritional vulnerability: Adolescent diets are frequently inadequate in B12, iron, zinc, and folate — the micronutrients most consistently associated with RAS susceptibility. A body that is growing rapidly while eating erratically is at high nutritional risk.

Stress and sleep disruption: Academic pressure, social stress, and irregular sleep — all concentrated in adolescence — activate the HPA axis, raise cortisol, and suppress salivary IgA, lowering mucosal protection. See how stress triggers canker sores for the mechanism.

Why the Decline After 30?

The decrease in RAS frequency after the third decade is less well-understood. Proposed explanations:

• Immune system stabilization — less reactive baseline
• Hormonal stabilization (particularly relevant for women post-childbearing)
• Progressive cross-immunity from repeated oral microbiome exposure (the hygiene hypothesis applied locally)
• Improved nutritional status as diet quality typically improves with age and income

Whatever the mechanism, the trajectory is consistent: RAS is a condition of younger adults, and for most people it becomes less frequent — though not necessarily absent — over time.

Family History: The Strongest Single Predictor

If you have a first-degree relative with RAS, your risk is substantially elevated. Studies of family clustering show:

• Both parents with RAS → ~90% chance in offspring (Sircus et al., 1957 — PMID: 13462399)
• One parent with RAS → ~45% chance in offspring
• No family history → ~20% chance (general population prevalence)

This is among the highest familial clustering seen in any benign oral condition and strongly implies a genetic component — though no single causative gene has been identified. RAS appears to be polygenic: multiple genetic variants, each contributing a modest effect, collectively determine baseline susceptibility.

What's Actually Inherited?

The genetic contribution operates primarily through immune system architecture:

HLA type: Several HLA alleles (the proteins that control how the immune system recognizes self versus non-self) are over-represented in RAS patients. HLA-B12, HLA-A2, and HLA-DR2 have been found at higher frequencies in RAS cohorts in different study populations (Albanidou-Farmaki et al., 2008 — PMID: 18279494). The specific alleles vary by population, suggesting that the underlying susceptibility is a feature of immune sensitivity rather than any single gene variant.

Mucosal barrier genetics: Some evidence suggests inherited differences in the structural integrity of the oral epithelium and the quality of the mucus layer may contribute — essentially, some people inherit a thinner or less robust mucosal barrier that's more easily breached.

Inflammatory cytokine profiles: Genetic variants affecting levels of IL-1β, TNF-α, and IL-6 — pro-inflammatory cytokines elevated during aphthous episodes — have been associated with RAS risk (Guimarães et al., 2007 — PMID: 17919929).

Family History Without a Diagnosis

One underappreciated complication: family history data is self-reported, and many parents with RAS never received a formal diagnosis. "Mouth sores" in a parent may or may not be RAS. The genetic studies likely undercount true family clustering because the baseline diagnosis rate is low.

Socioeconomic Status: Higher SES Means More Canker Sores

This one surprises people. Across multiple studies, RAS is more prevalent in higher-income, more-educated populations — the opposite of most chronic health conditions (Shulman, 2004 — PMID: 15060395; Kleinman et al., 1994 — PMID: 7965282).

The Hygiene Hypothesis

The leading explanation draws on the same framework used to explain the higher prevalence of allergies and autoimmune conditions in wealthier populations: the hygiene hypothesis.

The theory: in early childhood, exposure to diverse pathogens and environmental organisms trains the immune system toward tolerance and away from excessive inflammatory response. Children in lower-hygiene environments receive this training more thoroughly. Children in higher-hygiene environments, with fewer early infections and less microbial diversity, develop immune systems that are more reactive — more likely to mount exaggerated responses to perceived threats, including the aberrant self-directed response that produces aphthous ulcers.

This is speculative as applied specifically to RAS, but it aligns with the broader epidemiological pattern and is consistent with what's known about RAS immune dysregulation.

Alternative Explanations

Other factors may partially explain the SES gradient:

Diagnosis and recall bias: Higher-SES individuals are more likely to have seen a dentist who named the condition, making them more likely to report it accurately in surveys.

Dietary specificity: Higher-income diets, while generally higher quality, may be higher in certain acidic trigger foods (citrus, tomatoes, wine) that are associated with aphthous outbreaks in susceptible individuals.

Occupational stress type: Knowledge-worker stress (sustained cognitive load, deadline pressure) may be more chronically activating of the HPA axis than manual labor stress, which is more acute.

The SES pattern is real and robust across studies, but the mechanism is not definitively established.

Autoimmune and Gastrointestinal Conditions

Several specific medical conditions dramatically increase RAS prevalence — not because the condition itself causes canker sores, but because the underlying pathology drives nutritional deficiencies or immune dysregulation that lowers mucosal threshold.

Celiac Disease

Celiac patients have a substantially elevated rate of RAS — some studies report 2–5× the general population rate (Bucci et al., 2003 — PMID: 12543270). The mechanism is nutritional: celiac destroys the intestinal villi responsible for absorbing B12, iron, zinc, and folate. All four of these micronutrients are independently associated with RAS susceptibility. Celiac patients on a strict gluten-free diet who achieve mucosal healing often see RAS frequency normalize — which is one of the cleaner natural experiments confirming the nutritional hypothesis. See gluten-free diet and canker sores.

Crohn's Disease and IBD

Oral aphthous ulcers are a recognized extraintestinal manifestation of Crohn's disease and, to a lesser extent, ulcerative colitis. In Crohn's, the prevalence of oral aphthae runs at 20–30% compared to ~20% in the general population — a modest but consistent elevation (Plauth et al., 1991 — PMID: 1904945). In active disease, the rate is higher. Here both the inflammatory component (dysregulated mucosal immunity paralleling the intestinal pathology) and nutritional malabsorption contribute. See canker sores and Crohn's disease.

Behçet's Disease

Behçet's disease — a rare systemic vasculitis — is characterized by recurrent oral ulcers as a defining diagnostic feature. Nearly 100% of Behçet's patients develop oral ulcers that are clinically indistinguishable from common RAS. Behçet's has a notably higher prevalence along the historical Silk Road corridor (Turkey, Iran, Central Asia, Japan), reflecting the genetic susceptibility concentrated in those ancestral populations. This geographic pattern is about a specific HLA allele (HLA-B51) that is over-represented in those populations — not about ancestry broadly, and not about RAS in general.

Nutritional Deficiency Profiles

Deficiency in B12, iron, zinc, or folate is found at significantly elevated rates in RAS patients compared to matched controls. The relationship appears causal in both directions: deficiency lowers mucosal threshold, and correcting deficiency frequently reduces outbreak frequency.

The populations most at risk for these deficiencies — and therefore at elevated RAS risk through this pathway:

• Vegans and vegetarians: B12 is found almost exclusively in animal products. Dietary B12 deficiency is the most common nutritional cause of elevated RAS risk in otherwise healthy adults.
• Heavy menstruators: Iron deficiency anemia is common and directly linked to RAS. Women with heavy periods who don't compensate with dietary iron or supplementation are at elevated risk through this mechanism specifically.
• Elderly adults: B12 absorption decreases with age due to declining intrinsic factor production (parietal cell atrophy). Older adults with RAS often have borderline or frank B12 deficiency even on adequate dietary intake.
• People with gut malabsorption (celiac, Crohn's, gastric bypass, chronic antacid use): All the relevant micronutrients require intact small intestinal function for absorption.

If you fall into one of these groups, getting serum B12, ferritin, serum iron, and RBC folate tested is the single highest-yield diagnostic step available to you. See the supplements guide for what to do with the results.

What Doesn't Predict Canker Sores

Race and ethnicity broadly: Despite many studies across different populations, there is no consistent evidence that any racial or ethnic group has inherently higher RAS susceptibility after controlling for the factors above. Where apparent ethnic differences show up in the literature, they typically resolve to: HLA type (immune genetics that happen to be distributed differently across ancestral groups), nutritional deficiency rates that reflect diet and absorption differences, or healthcare access and diagnosis bias. The underlying biology of RAS — immune dysregulation, mucosal threshold, micronutrient status — operates the same way across all human populations.

Diet (generally): Certain foods trigger episodes in susceptible individuals (citrus, tomatoes, SLS in toothpaste), but food consumption patterns don't explain who gets RAS in the first place. Diet matters mainly through the nutritional deficiency pathway and SLS exposure.

Oral hygiene: No consistent evidence that people with better or worse oral hygiene have higher or lower RAS rates (independent of other factors). Some studies show a slight inverse relationship — worse hygiene, fewer aphthous ulcers — which again points toward the hygiene hypothesis.

Putting It Together: Who Should Pay Attention

If you're a woman between 15 and 35, have a parent or sibling with RAS, and have any of the risk factors for nutritional deficiency — you're in the highest-risk overlap zone. The practical implication is that these are the people most likely to see meaningful improvement from targeted intervention:

1. Get your B12, ferritin, iron, and folate tested — deficiency is common and correctable
2. Switch to SLS-free toothpaste — removes one consistent mucosal irritant
3. Track outbreaks against menstrual cycle if applicable — hormonal pattern recognition changes how you plan around it

For the full picture of how these risk factors interact with treatment options, see What Causes Canker Sores and the Supplements Guide.